Wockhardt Limited (WOCKPHARMA) showcases innovation, performance, and growth at its June 2026 investor conference.
Suven Life Sciences Limited (SUVEN) announces positive DSMB safety review and interim analysis from ongoing global Phase 3 study of Masupirdine in Alzheimer'.
Aurobindo Pharma Limited (AUROPHARMA) inaugurates TheraNym, a pioneering biologics contract manufacturing facility in Hyderabad, India, with MSD as its ancho.
Granules India Limited (GRANULES) announced its USFDA EIR for Chantilly Facility with a Voluntary Action Indicated (VAI) classification.
Max India Limited (MAXIND) inaugurates Antara Integrated Wellness Clinic, a pioneering clinic for chronic condition treatment in Gurugram.
Natco Pharma Limited (NSE: NATCO PHARM) announces FDA approval for Eribulin Mesylate Injection, a bioequivalent to Halaven®.
Lupin Limited (LUPIN) and Natco Pharma receive FDA approval for Eribulin Mesylate Injection, a bioequivalent to Halaven®.
Shilpa Medicare Limited (NSE: SHILPAMED) acquires 30.4% stake in Gate2Brain to advance brain cancer therapy.
Alkem Laboratories Limited (NSE: ALKEM) becomes the first in India to launch semaglutide in single-shot pre-filled syringes starting at INR 350.
Wanbury Limited (WANBURY) announced FY26 results with 117% YoY PAT growth, EPS doubling, and new API launches.